Intellia Therapeutics (NTLA) Q1 2026 Earnings

19FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-1.28
-1.16
-1.04
-0.92

Details

Expected EPS
-0.9549
Actual EPS
N/A
Surprise EPS
0.95
Surprise Percent
+100%

Description

Intellia Therapeutics (NTLA) will report earnings of for Q1 2026 on February 19, 2026.

0 Comments

Share your thoughts